Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$24.32 - $75.3 $68,290 - $211,442
-2,808 Reduced 88.61%
361 $27,000
Q1 2022

May 16, 2022

SELL
$24.73 - $51.25 $156,466 - $324,258
-6,327 Reduced 66.63%
3,169 $85,000
Q4 2021

Feb 14, 2022

BUY
$35.48 - $67.33 $262,481 - $498,107
7,398 Added 352.62%
9,496 $453,000
Q3 2021

Nov 15, 2021

SELL
$61.0 - $81.99 $893,589 - $1.2 Million
-14,649 Reduced 87.47%
2,098 $139,000
Q2 2021

Aug 16, 2021

BUY
$62.93 - $90.59 $1.05 Million - $1.52 Million
16,747 New
16,747 $1.31 Million

About Turning Point Therapeutics, Inc.


  • Ticker TPTX
  • Exchange NASDAQ
  • Shares Outstandng 50,074,300
More about TPTX
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.